Respiratory Virus Testing Guidance for Flu Season

AdventHealth has developed a respiratory virus testing algorithm to assist its providers this flu season. Physician leaders from AdventHealth’s emergency department, infectious disease, inpatient, pediatrics and pharmacy teams all collaborated to provide actionable guidance that ensures efficient testing – matching the right patient with the right test and/or vaccination at the right time.

Starting with direction from the Centers for Disease Control, Dr. Jose Alexander, medical director of the microbiology and virology department for AdventHealth’s Central Florida Division, worked across teams to ensure the health system’s algorithm is both widely applicable and customized for the community’s unique needs. The algorithm, which focuses on virus prevalence and historical data, vulnerable patient populations and test availability across AdventHealth facilities, was then reviewed and approved by its Lab and Test Utilization Committee.

Another member of the team who played a leading role was Dr. Tanya Agard, medical director of hospital medicine for AdventHealth’s Central Florida Division. She underscored the importance of providers familiarizing themselves with the algorithm as a best practice in support of their own clinical judgment.

“The algorithm does not override or supplant a provider’s clinical judgement,” noted Dr. Agard. “As we see patients for both testing and vaccine considerations, we must look at them as individuals. Rather than assume one person is the same as another in their age group, for instance, be sure to take the time to look at the specifics of their risk factors for complications, contraindications and whether they are immunosuppressed. These are all important aspects for providing personalized and consumer-focused, connected care in our community.”

Flu algorithm graphic

Recent News

12 items. To interact with these items, press Control-Option-Shift-Right Arrow. These items are in a slider. To advance slider forward, press Shift-Command-Right Arrow. To advance slider backward, press Shift-Command-Left Arrow.
News
New Study Published in the New England Journal of Medicine Shows the Addition of Regional Nodal Irradiation Does Not Decrease Rate of Invasive Breast Cancer Recurrence in Patients with Negative Axillary Nodes Following Neoadjuvant Chemotherapy

Findings of the phase III, multicenter, randomized NSABP B-51-RTOG 1304 clinical trial were recently published in the New England Journal of Medicine with AdventHealth Cancer Institute’s Dr. Mamounas...

Read Article about "New Study Published in the New England Journal of Medicine Shows the Addition of Regional Nodal Irradiation Does Not Decrease Rate of Invasive Breast Cancer Recurrence in Patients with Negative Axillary Nodes Following Neoadjuvant Chemotherapy "
News
AdventHealth Study Exploring the Use of MR-Guided Focused Ultrasound (MRgFUS) to Disrupt the Blood-Brain Barrier for Treatment of Alzheimer’s Disease

Under the leadership of Dr. Valeria Baldivieso and Dr. Chandan Reddy, the AdventHealth Research Institute is the first and only site in Orlando offering the Exablate Blood-Brain Barrier (BBB)...

Read Article about "AdventHealth Study Exploring the Use of MR-Guided Focused Ultrasound (MRgFUS) to Disrupt the Blood-Brain Barrier for Treatment of Alzheimer’s Disease"
News
AdventHealth’s Karen D. Corbin, PhD, RD, Contributed to New American Diabetes Association Consensus Statement on Liver Disease in Diabetes

Metabolic dysfunction associated steatotic liver disease (MASLD), formerly referred to as nonalcoholic fatty liver disease (NAFLD), affects about 70% of people with type 2 diabetes, placing them at...

Read Article about "AdventHealth’s Karen D. Corbin, PhD, RD, Contributed to New American Diabetes Association Consensus Statement on Liver Disease in Diabetes "
View More Articles